Current Studies

Research is an important part of our department, and we specialize in innovative, transdisciplinary work. We have several ongoing studies. We invite you to read about some of our ongoing studies below and to contact our research staff for more information. All research studies are completely voluntary.

Depression-related Studies

Major Depression Disorder in Adolescents
Status:  Open for participation

Research Contact Person: Abhishek Allam | tel: (520) 626-7325 or email
Principal Investigator:  Karen Weihs, MD
The purpose of this study is to evaluate the efficacy, safety and tolerability of Levomilnacipran relative to placebo in adolescents with Major depressive disorder.  The eligibility criteria are adolescents aged 12-17, and have symptoms of depression. The duration of the study is 10 weeks. Study drug will be given at no cost and reimbursement is available for time and travel. For additional information and to know about eligibility, please contact Abhishek Allam at (520) 626-7325.

Status:  Open for participation
Research Contact Person: Abhishek Allam | tel: (520) 626-7325 or email
Principal Investigator:  Karen Weihs, MD
The purpose of this study is to evaluate the efficacy of Vortioxetine relative to placebo in adolescents with Major depressive disorder.  The eligibility criteria are adolescents aged 12-17, and have symptoms of depression. The duration of the study is up to 9 months and includes Psychotherapy (talk-therapy sessions). Study drug and Talk-therapy is given at no cost and reimbursement is available for time and travel. For additional information and to know about eligibility, please contact Abhishek Allam at (520) 626-7325.

Other Studies

Typical Daily Experiences, Ischemia and Repolarization in Coronary Artery Disease
Status: Open for participation

Sponsor: National Institutes of Health
Principal Investigator: Richard Lane, MD, PhD
This study examines the role of every day experiences as they relate to coronary artery disease (CAD). CAD is the most common setting in which sudden cardiac death (SCD) occurs. SCD is the leading cause of death in the United States.